HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
15.32
+0.34 (2.27%)
Apr 9, 2026, 1:33 PM EDT - Market open
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.48 billion as of April 9, 2026. Its market cap has decreased by -5.68% in one year.
Market Cap
2.48B
Enterprise Value
1.23B
1-Year Change
-5.68%
Ranking
Category
Stock Price
$15.32
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.48B, an increase of 55.35%. That is a compound annual growth rate of 4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 2.61B | 12.41% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amneal Pharmaceuticals | 3.93B |
| Kiniksa Pharmaceuticals International, | 3.75B |
| Liquidia | 3.29B |
| Supernus Pharmaceuticals | 2.93B |
| Prestige Consumer Healthcare | 2.63B |
| BioCryst Pharmaceuticals | 2.41B |
| Phibro Animal Health | 2.26B |
| Bausch Health Companies | 1.95B |